| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |